Primary Care Clinics in Lake Station, IN Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Fernando H. Rivera M.d. Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3099 Central Ave, Lake Station, IN 46405 Phone: 219-962-1418 Fax: 219-962-4516 |
Northshore Health Centers, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 2490 Central Ave Ste B, Lake Station, IN 46405 Phone: 219-962-5909 Fax: 219-962-5981 |
Northshore Edison Senior High School Family Medicine Medicare: Medicare Enrolled Practice Location: 3304 Parkside Ave, Lake Station, IN 46405 Phone: 219-763-8112 Fax: 219-962-1860 |
News Archive
FSMB partners with NAM to form Action Collaborative on countering opioid epidemic
In recognition of the need for a national coordinated and collective response to the epidemic of opioid addiction in the U.S., the Federation of State Medical Boards is partnering with the National Academy of Medicine and 35 organizations to form the Action Collaborative on Countering the U.S. Opioid Epidemic.
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon Nitride Center
Amedica announced today that it has filed a submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding ("Valeo CCsC") with the U.S. Food and Drug Administration ("FDA") relating to its composite silicon nitride spinal interbody devices.
Bespoke filtration equipment facilitates delivery of critical drugs to leading children's hospital
Amazon Filters has supplied a major pharmaceutical manufacturer with bespoke filtration equipment enabling them to fulfil a contract to deliver critical drugs to a leading children's hospital.
Small-molecule immunotherapeutics could steer immune defense against fungal pathogens
Fungal infections represent an increasing health crisis, especially for immune-deficient patients. American scientists now report in the journal Angewandte Chemie that specific help could be provided by small-molecule immunotherapeutics with novel mechanism of action.
New investigational immunotherapy benefits people with advanced urothelial bladder cancer
A new investigational immunotherapy MPDL3280A has been shown to shrink tumours in 43% of people (13/30) who had previously been treated for advanced urothelial bladder cancer (UBC) with a specific type of tumour (PD-L1 positive).
› Verified 5 days ago